|
Market Closed -
Other stock markets
|
After hours 12:00:44 pm | |||
| 2.410 EUR | +0.84% |
|
2.390 | -0.83% |
| Mar. 23 | BRAIN Biotech Secures European Patent for Genome-editing Technology | MT |
| Feb. 24 | BRAIN Biotech AG Reports Earnings Results for the First Quarter Ended December 31, 2025 | CI |
Company Valuation: BRAIN Biotech AG
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 220.7 | 96.35 | 92.63 | 46.32 | 47.63 | 52.22 | - | - |
| Change | - | -56.34% | -3.85% | -50% | 2.83% | 9.63% | - | - |
| Enterprise Value (EV) 1 | 217 | 111.8 | 116.1 | 55.58 | 65.18 | 76.27 | 80 | 84.04 |
| Change | - | -48.48% | 3.88% | -52.14% | 17.28% | 17.01% | 4.88% | 5.06% |
| P/E ratio | -40.4x | -14.7x | -11.2x | -4.16x | -4.04x | -7.64x | -32.8x | -9.6x |
| PBR | 5.69x | 3.25x | 4.25x | 3.67x | 25.9x | -19.2x | -12.3x | -2.43x |
| PEG | - | -0.7x | -0.4x | -0.1x | -0.69x | 0.2x | 0.4x | -0x |
| Capitalization / Revenue | 5.75x | 1.95x | 1.67x | 0.85x | 0.96x | 0.92x | 0.78x | 0.81x |
| EV / Revenue | 5.65x | 2.26x | 2.1x | 1.02x | 1.31x | 1.34x | 1.2x | 1.31x |
| EV / EBITDA | -86.8x | -85.4x | -141x | -13.9x | -32.2x | 24.6x | 5.63x | - |
| EV / EBIT | -33.1x | -19.8x | -21.2x | -6.28x | -9.12x | -21.6x | 32.1x | 115x |
| EV / FCF | -42x | -14.8x | -16.9x | -10.5x | -6.05x | -9.42x | -11x | - |
| FCF Yield | -2.38% | -6.77% | -5.9% | -9.56% | -16.5% | -10.6% | -9.13% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.25 | -0.3 | -0.38 | -0.51 | -0.54 | -0.3128 | -0.0729 | -0.249 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 38.4 | 49.5 | 55.34 | 54.6 | 49.62 | 56.97 | 66.57 | 64.26 |
| EBITDA 1 | -2.5 | -1.309 | -0.826 | -4 | -2.025 | 3.1 | 14.2 | - |
| EBIT 1 | -6.548 | -5.648 | -5.48 | -8.852 | -7.151 | -3.539 | 2.496 | 0.7285 |
| Net income 1 | -4.972 | -6.59 | -8.279 | -11.13 | -11.74 | -6.808 | -1.628 | -5.44 |
| Net Debt 1 | -3.698 | 15.43 | 23.48 | 9.259 | 17.55 | 24.06 | 27.78 | 31.82 |
| Reference price 2 | 10.100 | 4.410 | 4.240 | 2.120 | 2.180 | 2.390 | 2.390 | 2.390 |
| Nbr of stocks (in thousands) | 21,847 | 21,847 | 21,847 | 21,847 | 21,847 | 21,847 | - | - |
| Announcement Date | 1/17/22 | 1/16/23 | 1/17/24 | 1/15/25 | 1/14/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.64x | 1.34x | 24.6x | -.--% | 61.12M | |
| -4.07x | 5.81x | -14.09x | -.--% | 203M | |
| 41.38x | 13.73x | 26.72x | -.--% | 174M | |
| -5.86x | 7.72x | -3.73x | - | 77.02M | |
| Average | 5.95x | 7.15x | 8.38x | 0% | 128.65M | |
| Weighted average by Cap. | 10.59x | 8.24x | 5.84x | 0% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- BNN Stock
- Valuation BRAIN Biotech AG
Select your edition
All financial news and data tailored to specific country editions
